Regulation of neutral sphingomyelinase-2 by GSH: A new insight to the role of oxidative stress in aging-associated inflammation

Journal of Lipid Research

Volumn 48, Issue 11, 2007, Pages 2443-2452

  Rutkute, Kristina ^a   Asmis, Reto H ^b   Nikolova Karakashian, Mariana N ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

C Jun N terminal kinase; Calorie restriction; Ceramide; Interleukin 1 receptor associated kinase 1; Reduced glutathione

Indexed keywords

ACETYLCYSTEINE; GLUTATHIONE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINOMYELINASE 2; UNCLASSIFIED DRUG;

AGING; ANIMAL CELL; ARTICLE; CALORIC RESTRICTION; CELL FUNCTION; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; GLUTATHIONE METABOLISM; INFLAMMATION; LIVER CELL; MALE; MOLECULAR MIMICRY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN LOCALIZATION; PROTEIN STABILITY; RAT;

AGING; ANIMALS; CALORIC RESTRICTION; GLUTATHIONE; INFLAMMATION; INTERLEUKIN-1BETA; LIVER; MALE; OXIDATIVE STRESS; RATS; RATS, INBRED F344; SPHINGOMYELIN PHOSPHODIESTERASE; UP-REGULATION;

EID: 35848937327     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700227-JLR200     Document Type: Article

References (51)

1. Ballou, S. P., F. B. Lozanski, S. Hodder, D. L. Rzewnicki, L. C. Mion, J. D. Sipe, A. B. Ford, and I. Kushner. 1996. Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons. Age Ageing. 25: 224-230.
2. Hsieh, C. C., J. I. Rosenblatt, and J. Papaconstantinou. 2003. Age-associated changes in SAPK/JNK and p38 MAPK signaling in response to the generation of ROS by 3-nitropropionic acid. Mech. Ageing Dev. 124: 733-746.
3. Supakar, P. C., M. H. Jung, C. S. Song, B. Chatterjee, and A. K. Roy. 1995. Nuclear factor kappa B functions as a negative regulator for the rat androgen receptor gene and NF-kappa B activity increases during the age-dependent desensitization of the liver. J. Biol. Chem. 270: 837-842.
4. Hsieh, C. C., W. Xiong, Q. Xie, J. P. Rabek, S. G. Scott, M. R. An, P. D. Reisner, D. T. Kuninger, and J. Papaconstantinou. 1998. Effects of age on the posttranscriptional regulation of CCAAT/enhancer binding protein alpha and CCAAT/enhancer binding protein beta isoform synthesis in control and LPS-treated livers. Mol. Biol. Cell. 9: 1479-1494.
5. Chung, H. Y., H. J. Kim, J. W. Kim, and B. P. Yu. 2001. The inflammation hypothesis of aging: molecular modulation by calorie restriction. Ann. N. Y. Acad. Sci. 928: 327-335.
6. Di Iorio, A., L. Ferrucci, E. Sparvieri, A. Cherubini, S. Volpato, A. Corsi, M. Bonafe, C. Franceschi, G. Abate, and R. Paganelli. 2003. Serum IL-1beta levels in health and disease: a population-based study. The InCHIANTI Study. Cytokine. 22: 198-205.
7. Roubenoff, R., T. B. Harris, L. W. Abad, P. W. Wilson, G. E. Dallal, and C. A. Dinarello. 1998. Monocyte cytokine production in an elderly population: effect of age and inflammation. J. Gerontol. A Biol. Sci. Med. Sci. 53: M20-M26.
8. Tang, Y., L. Di Pietro, Y. Feng, and X. Wang. 2000. Increased TNF-alpha and PGI(2), but not NO release from macrophages in 18-month-old rats. Mech. Ageing Dev. 114: 79-88.
9. Wu, D., M. Marko, K. Claycombe, K. E. Paulson, and S. N. Meydani. 2003. Ceramide-induced and age-associated increase in macrophage COX-2 expression is mediated through up-regulation of NF-kappa B activity. J. Biol. Chem. 278: 10983-10992.
10. Rutkute, K., A. Karakashian, N. Giltiay, A. Dobierzewska, and M. N. Nikolova-Karakashian. 2007. Aging in rat causes hepatic hyperresponsiveness to interleukin 1beta which is mediated by neutral sphingomyelinase-2. Hepatology. In press.
11. Wesche, H., W. J. Henzel, W. Shillinglaw, S. Li, and Z. Cao. 1997. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity. 7: 837-847.
12. Cao, Z., J. Xiong, M. Takeuchi, T. Kurama, and D. V. Goeddel. 1996. TRAF6 is a signal transducer for interleukin-1. Nature. 383: 443-446.
13. Jiang, Z., J. Ninomiya-Tsuji, Y. Qian, K. Matsumoto, and X. Li. 2002. Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol. Cell. Biol. 22: 7158-7167.
14. Ninomiya-Tsuji, J., K. Kishimoto, A. Hiyama, J. Inoue, Z. Cao, and K. Matsumoto. 1999. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature. 398: 252-256.
15. Yamin, T. T., and D. K. Miller. 1997. The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation. J. Biol. Chem. 272: 21540-21547.
16. Cuschieri, J., D. Gourlay, I. Garcia, S. Jelacic, and R. V. Maier. 2004. Implications of proteasome inhibition: an enhanced macrophage phenotype. Cell. Immunol. 227: 140-147.
17. Li, L., S. Cousart, J. Hu, and C. E. McCall. 2000. Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J. Biol. Chem. 275: 23340-23345.
18. Adib-Conquy, M., and J. M. Cavaillon. 2002. Gamma interferon and granulocyte/monocyte colony-stimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression. J. Biol. Chem. 277: 27927-27934.
19. Karakashian, A. A., N. V. Giltiay, G. M. Smith, and M. N. Nikolova-Karakashian. 2004. Expression of neutral sphingomyelinase-2 (NSMase-2) in primary rat hepatocytes modulates IL-beta-induced JNK activation. FASEB J. 18: 968-970.
20. Marchesini, N., C. Luberto, and Y. A. Hannun. 2003. Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism. J. Biol. Chem. 278: 13775-13783.
21. Petkova, D. H., A. B. Momchilova-Pankova, T. T. Markovska, and K. S. Koumanov. 1988. Age-related changes in rat liver plasma membrane sphingomyelinase activity. Exp. Gerontol. 23: 19-24.
22. Lightle, S. A., J. I. Oakley, and M. N. Nikolova-Karakashian. 2000. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging. Mech. Ageing Dev. 120: 111-125.
23. Cutler, R. G., J. Kelly, K. Storie, W. A. Pedersen, A. Tammara, K. Hatanpaa, J. C. Troncoso, and M. P. Mattson. 2004. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 101: 2070-2075.
24. Claycombe, K. J., D. Wu, M. Nikolova-Karakashian, H. Palmer, A. Beharka, K. E. Paulson, and S. N. Meydani. 2002. Ceramide mediates age-associated increase in macrophage cyclooxygenase-2 expression. J. Biol. Chem. 277: 30784-30791.
25. Venable, M. E., G. C. Blobe, and L. M. Obeid. 1994. Identification of a defect in the phospholipase D/diacylglycerol pathway in cellular senescence. J. Biol. Chem. 269: 26040-26044.
26. Kraveka, J. M., L. Li, J. Bielawski, L. M. Obeid, and B. Ogretmen. 2003. Involvement of endogenous ceramide in the inhibition of telomerase activity and induction of morphologic differentiation in response to all-trans-retinoic acid in human neuroblastoma cells. Arch. Biochem. Biophys. 419: 110-119.
27. Acharya, U., S. Patel, E. Koundakjian, K. Nagashima, X. Han, and J. K. Acharya. 2003. Modulating sphingolipid biosynthetic pathway rescues photoreceptor degeneration. Science. 299: 1740-1743.
28. D'Mello, N. P., A. M. Childress, D. S. Franklin, S. P. Kale, C. Pinswasdi, and S. M. Jazwinski. 1994. Cloning and characterization of LAG1, a longevity-assurance gene in yeast. J. Biol. Chem. 269: 15451-15459.
29. Schorling, S., B. Vallee, W. P. Barz, H. Riezman, and D. Oesterhelt. 2001. Lag1p and Lac1p are essential for the acyl-CoA-dependent ceramide synthase reaction in Saccharomyces cerevisiae. Mol. Biol. Cell. 12: 3417-3427.
30. Liu, B., and Y. A. Hannun. 1997. Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione. J. Biol. Chem. 272: 16281-16287.
31. Liu, B., N. Andrieu-Abadie, T. Levade, P. Zhang, L. M. Obeid, and Y. A. Hannun. 1998. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J. Biol. Chem. 273: 11313-11320.
32. Yoshimura, S., Y. Banno, S. Nakashima, K. Hayashi, H. Yamakawa, M. Sawada, N. Sakai, and Y. Nozawa. 1999. Inhibition of neutral sphingomyelinase activation and ceramide formation by glutathione in hypoxic PC12 cell death. J. Neurochem. 73: 675-683.
33. Tsyupko, A. N., L. B. Dudnik, R. P. Evstigneeva, and A. V. Alessenko. 2001. Effects of reduced and oxidized glutathione on sphingomyelinase activity and contents of sphingomyelin and lipid peroxidation products in murine liver. Biochemistry (Mosc.). 66: 1028-1034.
34. Bernardo, K., O. Krut, K. Wiegmann, D. Kreder, M. Micheli, R. Schafer, A. Sickman, W. E. Schmidt, J. M. Schroder, H. E. Meyer, et al. 2000. Purification and characterization of a magnesium-dependent neutral sphingomyelinase from bovine brain. J. Biol. Chem. 275: 7641-7647.
35. Chen, J., M. Nikolova-Karakashian, A. H. Merrill, Jr., and E. T. Morgan. 1995. Regulation of cytochrome P450 2C11 (CYP2C11) gene expression by interleukin-1, sphingomyelin hydrolysis, and ceramides in rat hepatocytes. J. Biol. Chem. 270: 25233-25238.
36. Nikolova-Karakashian, M., E. T. Morgan, C. Alexander, D. C. Liotta, and A. H. Merrill, Jr. 1997. Bimodal regulation of ceramidase by interleukin-1beta. Implications for the regulation of cytochrome p450 2C11. J. Biol. Chem. 272: 18718-18724.
37. Bligh, E., and W. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. 37: 911-917.
38. Merrill, A. H., Jr., E. Wang, R. E. Mullins, W. C. Jamison, S. Nimkar, and D. C. Liotta. 1988. Quantitation of free sphingosine in liver by high-performance liquid chromatography. Anal. Biochem. 171: 373-381.
39. Asmis, R., Y. Wang, L. Xu, M. Kisgati, J. G. Begley, and J. J. Mieyal. 2005. A novel thiol oxidation-based mechanism for adriamycin-induced cell injury in human macrophages. FASEB J. 19: 1866-1868.
40. Palomero, J., A. I. Galan, M. E. Munoz, M. J. Tunon, J. Gonzalez-Gallego, and R. Jimenez. 2001. Effects of aging on the susceptibility to the toxic effects of cyclosporin A in rats. Changes in liver glutathione and antioxidant enzymes. Free Radic. Biol. Med. 30: 836-845.
41. Jung, K., and W. Henke. 1996. Developmental changes of antioxidant enzymes in kidney and liver from rats. Free Radic. Biol. Med. 20: 613-617.
42. Rebrin, I., S. Kamzalov, and R. S. Sohal. 2003. Effects of age and caloric restriction on glutathione redox state in mice. Free Radic. Biol. Med. 35: 626-635.
43. Rikans, L. E., and S. D. Kosanke. 1984. Effect of aging on liver glutathione levels and hepatocellular injury from carbon tetrachloride, allyl alcohol or galactosamine. Drug Chem. Toxicol. 7: 595-604.
44. Hagen, T. M., V. Vinarsky, C. M. Wehr, and B. N. Ames. 2000. (R)-Alpha-lipoic acid reverses the age-associated increase in susceptibility of hepatocytes to tert-butylhydroperoxide both in vitro and in vivo. Antioxid. Redox Signal. 2: 473-483.
45. Vericel, E., M. Narce, L. Ulmann, J. P. Poisson, and M. Lagarde. 1994. Age-related changes in antioxidant defence mechanisms and peroxidation in isolated hepatocytes from spontaneously hypertensive and normotensive rats. Mol. Cell. Biochem. 132: 25-29.
46. Gouaze, V., M. E. Mirault, S. Carpentier, R. Salvayre, T. Levade, and N. Andrieu-Abadie. 2001. Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells. Mol. Pharmacol. 60: 488-496.
47. Bello, R. I., C. Gomez-Diaz, M. I. Buron, F. J. Alcain, P. Navas, and J. M. Villalba. 2005. Enhanced anti-oxidant protection of liver membranes in long-lived rats fed on a coenzyme Q10-supplemented diet. Exp. Gerontol. 40: 694-706.
48. Ayasolla, K., M. Khan, A. K. Singh, and I. Singh. 2004. Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E. Free Radic. Biol. Med. 37: 325-338.
49. Martin, S. F., H. Sawai, J. M. Villalba, and Y. A. Hannun. 2007. Redox regulation of neutral sphingomyelinase-1 activity in HEK293 cells through a GSH-dependent mechanism. Arch. Biochem. Biophys. 459: 295-300.
50. Lang, C. H., G. J. Nystrom, and R. A. Frost. 1999. Regulation of IGF binding protein-1 in Hep G2 cells by cytokines and reactive oxygen species. Am. J. Physiol. 276: G719-G727.
51. Bose, C., C. Bhuvaneswaran, and K. B. Udupa. 2005. Age-related alteration in hepatic acyl-CoA: cholesterol acyltransferase and its relation to LDL receptor and MAPK. Mech. Ageing Dev. 126: 740-751.